The Evolving Burden of Drug Use Associated Infective Endocarditis in the United States
- 6 May 2020
- journal article
- research article
- Published by Elsevier BV in The Annals of Thoracic Surgery
- Vol. 110 (4), 1185-1192
- https://doi.org/10.1016/j.athoracsur.2020.03.089
Abstract
No abstract availableFunding Information
- National Institutes of Health (5T32HL069749)
- National Institute of Allergy and Infectious Diseases (T32AI070114)
- Society of Thoracic Surgeons
This publication has 28 references indexed in Scilit:
- Impact of Substance Use Disorder on Midterm Mortality After Valve Surgery for EndocarditisThe Annals of Thoracic Surgery, 2019
- The opioid epidemic and intravenous drug–associated endocarditis: A path forwardThe Journal of Thoracic and Cardiovascular Surgery, 2019
- Long-term Outcomes Are Poor in Intravenous Drug Users Following Infective Endocarditis, Even After SurgeryClinical Infectious Diseases, 2019
- Risk of reoperative valve surgery for endocarditis associated with drug useThe Journal of Thoracic and Cardiovascular Surgery, 2019
- Drug and Opioid-Involved Overdose Deaths — United States, 2013–2017Morbidity and Mortality Weekly Report (MMWR), 2018
- Trends in Drug Use–Associated Infective Endocarditis and Heart Valve Surgery, 2007 to 2017Annals of Internal Medicine, 2018
- Repeat Infective Endocarditis in Persons Who Inject Drugs: “Take Another Little Piece of my Heart”*Open Forum Infectious Diseases, 2018
- HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014–2015The New England Journal of Medicine, 2016
- Surgical outcomes of infective endocarditis among intravenous drug usersThe Journal of Thoracic and Cardiovascular Surgery, 2016
- Injection Drug Use and Outcomes After Surgical Intervention for Infective EndocarditisThe Annals of Thoracic Surgery, 2015